| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 12,920,000 | 13,099,000 | 13,648,000 | 16,629,000 | | Cost of Revenue | 2,842,000 | 2,586,000 | 2,814,000 | 3,907,000 | | | Gross Profit | 10,078,000 | 10,513,000 | 10,834,000 | 12,722,000 | | | Operating Expenses | | Research Development | 2,065,000 | 2,225,000 | 2,212,000 | 2,290,000 | | Selling General and Administrative | 3,531,000 | 4,261,000 | 3,894,000 | 4,493,000 | | Non Recurring |
-
| 40,000 | 290,000 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,482,000 | 3,987,000 | 4,438,000 | 5,939,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 283,000 | 155,000 | (388,000) | (301,000) | | Earnings Before Interest And Taxes | 4,765,000 | 4,142,000 | 4,050,000 | 5,638,000 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 4,765,000 | 4,142,000 | 4,050,000 | 5,638,000 | | Income Tax Expense | 1,191,000 | 1,097,000 | 1,073,000 | 1,464,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,574,000 | 3,045,000 | 2,977,000 | 4,174,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,574,000 | 3,045,000 | 2,977,000 | 4,174,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,574,000 | $3,045,000 | $2,977,000 | $4,174,000 |
|
0.29% Nasdaq 
0.12 (0.40%) 
Income Statement
